SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950135-05-002473
Filing Date
2005-05-02
Accepted
2005-05-02 17:26:42
Documents
14
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. FORM 10-K/A b53303kae10vkza.htm 10-K/A 277774
2 EX-4.2 INDENTURE DATED AS OF 5-4-2004 b53303kaexv4w2.txt EX-4.2 160245
3 EX-4.3 SUPPLEMENTAL INDENTURE DATED AS OF 5-4-2004 b53303kaexv4w3.txt EX-4.3 148666
4 EX-10.18 EXECUTIVE NONQUALIFIED EXCESS PLAN b53303kaexv10w18.txt EX-10.18 106289
5 EX-10.21 REVISED EMPLOYMENT AGREEMENT DATED 2-26-2002 b53303kaexv10w21.txt EX-10.21 13133
6 EX-10.38 AMENDMENT TO 1993 LONG-TERM INCENTIVE PLAN b53303kaexv10w38.txt EX-10.38 22493
7 EX-10.39 AMENDMENT TO 2001 NON-OFFICER, NON-DIRECTOR EMPLOYEE STOCK INCENTIVE PL b53303kaexv10w39.txt EX-10.39 21061
8 EX-10.40 AMENDMENT TO 2002 STOCK INCENTIVE PLAN b53303kaexv10w40.txt EX-10.40 20938
9 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b53303kaexv21w1.txt EX-21.1 1267
10 EX-23.2 CONSENT OF ERNST & YOUNG LLP b53303kaexv23w2.txt EX-23.2 960
11 EX-31.1 SECTION 302 CERTIFICATION OF CEO b53303kaexv31w1.txt EX-31.1 4330
12 EX-31.2 SECTION 302 CERTIFICATION OF CFO b53303kaexv31w2.txt EX-31.2 4298
13 EX32.1 SECTION 906 CERTIFICATION OF CEO b53303kaexv32w1.txt EX-32.1 1496
14 EX-32.2 SECTION 906 CERTIFICATION OF CFO b53303kaexv32w2.txt EX-32.2 1475
  Complete submission text file 0000950135-05-002473.txt   785892
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21481 | Film No.: 05791966
SIC: 2836 Biological Products, (No Diagnostic Substances)